<DOC>
	<DOCNO>NCT02018887</DOCNO>
	<brief_summary>The purpose study evaluate safe LY2969822 ( study drug ) whether cause side effect . The study also measure much study drug get blood stream long take body get rid study drug . This first time study drug give participant . This study research purpose intend treat medical condition .</brief_summary>
	<brief_title>A Study LY2969822 Healthy Participants</brief_title>
	<detailed_description>Participants Part A complete three study period , together last 40 day . Participants Parts B C complete one study period last 17 day , total study time 40 day . Each participant may enroll one part . Screening require within 28 day prior start study participant .</detailed_description>
	<criteria>Male participant must agree use reliable method birth control addition partner use another method duration study 3 month last dose LY2969822 Female participant must childbearing potential Participants body mass index ( BMI ) 18.5 29.9 kilogram per meter square ( kg/m^2 ) , inclusive , screen Have participate , within last 30 day ( prior first dose study ) , clinical trial involve investigational product Have significant history current cardiovascular , respiratory , hepatic , renal , gastrointestinal ( GI ) , endocrine , hematological , neurological disorder capable significantly alter absorption , metabolism , elimination drug ; constitute risk take study medication ; interfere interpretation data Intended use overthecounter medication within 14 day prior dose study exception vitamins mineral supplement occasional paracetamol acetaminophen Intended use herbal supplement prescription medication , stable dos thyroid estrogen hormone replacement , within 14 day prior dose study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>